Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Journal of Shahrekord University of Medical Sciences. 2012; 14 (1): 28-33
in Persian | IMEMR | ID: emr-128851

ABSTRACT

Polycystic ovarian syndrome [PCOS] accompanied with obesity and insulin resistance. Many findings have shown that fat tissue has an important role in creating and resisting of various disorders in PCOS. On the other hand, thyroid has an obvious and dominant role in metabolism [specially in the metabolism of lipids and carbohydrates]. Both PCOS and thyroid diseases are accompanied with disruption in function of hypothalamus - pituitary -gonad axis. This study aimed at finding the relationship between antithyroid antibodies and polycystic ovary syndrome. In this descriptive analytical study two groups of 54 women with the age ranges of 15 to 45 years from Shahrekord, Iran were selected and consecutively were entered the study. The first group [control group], did not have any thyroid disease, systemic disorders or PCOS based on the history, physical examinations and blood tests and they did not use any medicine. The second group [patients groups], did not have any thyroid diseases and systemic disorders based on the history, physical examinations and blood tests but they had PCOS. Antithyroid antibodies in both groups were measured and compared using K[2], t test and ANOVA. There was no significant difference in the prevalence and levels of antithyroid antibodies between PCOS group and control subjects [P>0.05]. The level of [T3] and [T4] was significantly higher in polycystic ovary syndrome than in control group [P<0.05]. It does not seem that to be more prevalent than in the healthy women and it is unlikely that they have an important role in pathophysiology of the disease


Subject(s)
Humans , Female , Prevalence , Autoantibodies , Immunoglobulins, Thyroid-Stimulating , Long-Acting Thyroid Stimulator , Thyroid Diseases
SELECTION OF CITATIONS
SEARCH DETAIL